Agenus Inc (AGEN)
10.44
-1.27
(-10.85%)
USD |
NASDAQ |
May 10, 16:00
10.44
0.00 (0.00%)
After-Hours: 18:32
Agenus Cash from Operations (TTM): -224.20M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -224.20M |
September 30, 2023 | -231.14M |
June 30, 2023 | -198.10M |
March 31, 2023 | -181.51M |
December 31, 2022 | -175.37M |
September 30, 2022 | -150.96M |
June 30, 2022 | 12.60M |
March 31, 2022 | 0.498M |
December 31, 2021 | 10.14M |
September 30, 2021 | -2.518M |
June 30, 2021 | -165.52M |
March 31, 2021 | -147.34M |
December 31, 2020 | -139.10M |
September 30, 2020 | -135.29M |
June 30, 2020 | -131.44M |
March 31, 2020 | -129.77M |
December 31, 2019 | -18.68M |
September 30, 2019 | -22.71M |
June 30, 2019 | -19.43M |
March 31, 2019 | -14.26M |
December 31, 2018 | -131.10M |
September 30, 2018 | -121.15M |
June 30, 2018 | -122.80M |
March 31, 2018 | -119.65M |
December 31, 2017 | -94.23M |
Date | Value |
---|---|
September 30, 2017 | -84.47M |
June 30, 2017 | -82.15M |
March 31, 2017 | -73.26M |
December 31, 2016 | -79.96M |
September 30, 2016 | -83.44M |
June 30, 2016 | -77.63M |
March 31, 2016 | -72.00M |
December 31, 2015 | -47.18M |
September 30, 2015 | -38.09M |
June 30, 2015 | -28.19M |
March 31, 2015 | -24.81M |
December 31, 2014 | -38.23M |
September 30, 2014 | -33.27M |
June 30, 2014 | -29.60M |
March 31, 2014 | -25.76M |
December 31, 2013 | -19.53M |
September 30, 2013 | -17.27M |
June 30, 2013 | -16.47M |
March 31, 2013 | -14.15M |
December 31, 2012 | 1.013M |
September 30, 2012 | 0.1096M |
June 30, 2012 | 0.3471M |
March 31, 2012 | -0.3326M |
December 31, 2011 | -16.25M |
September 30, 2011 | -13.51M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-231.14M
Minimum
Sep 2023
12.60M
Maximum
Jun 2022
-107.89M
Average
-135.29M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Protalix BioTherapeutics Inc | -1.318M |
InfuSystems Holdings Inc | 11.22M |
PAVmed Inc | -52.04M |
Allogene Therapeutics Inc | -237.73M |
Pfizer Inc | 8.578B |